1236290-45-1

Basic information

• Product Name: NTP-1030
• Synonyms: NTP-1030
• CAS NO: 1236290-45-1
• Molecular Weight: 399.855
• Mol File: 1236290-45-1.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: NTP-1030(CAS DataBase Reference)
• NIST Chemistry Reference: NTP-1030(1236290-45-1)
• EPA Substance Registry System: NTP-1030(1236290-45-1)

Safety Data

• Hazardous Substances Data: 1236290-45-1(Hazardous Substances Data)

Upstream product

• 110-91-8 morpholine 
• 54-31-9 4-chloro-2-furfurylamino-5-sulfamoyl-benzoic acid 

Relevant articles and documents

BUMETANIDE, FUROSEMIDE, PIRETANIDE, AZOSEMIDE, AND TORSEMIDE ANALOGS, COMPOSITIONS AND METHODS OF USE

The present invention provides bumetanide, furosemide, piretanide, azosemide, and torsemide analogs and compositions comprising such analogs. The present invention also provides pharmaceutical compositions containing these bumetanide, furosemide, piretanide, azosemide, and torsemide analogs and methods for their use. All of these analogs are particularly useful for the treatment and/or prophylaxis of conditions that involve the Na+K+Cl- co-transporter or GABAA receptor including but not limited to addictive disorders, Alzheimer's Disease, anxiety disorders, ascites, autism, bipolar disorder, cancer, depression, endothelial corneal dystrophy, edema, epilepsy, glaucoma, Huntington's Disease, insomnia, ischemia, migraine, migraine with aura, neuropathic pain, nociceptive neuralgia, nociceptive pain, ocular diseases, pain, Parkinson's disease, personality disorders, postherpetic neuralgia, psychosis, schizophrenia, seizure disorders, tinnitus, and withdrawal syndromes.